13F-HR filed by GENERAL ATLANTIC, L.P.
GENERAL ATLANTIC, L.P. filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 22 holding rows worth $4,305,303,376.
- Accession
- 0000950142-24-001354
- Filer
- CIK 1017645
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 22 entries on the cover page, a total value of $4,305,303,376 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,305,303,376 with VALUE read as dollars as filed, 13F file number 028-03473. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DLOCAL LTD | G29018101 | CLASS A COM | 63,906,695 | $939,428,417 | dollars as filed | |
| XP INC CL A | G98239109 | Stock | 29,617,733 | $759,991,029 | dollars as filed | |
| ALKAMI TECHNOLOGY INC | 01644J108 | COM | 18,729,806 | $460,191,333 | dollars as filed | |
| HIRERIGHT HOLDINGS CORPORATI | 433537107 | COM | 32,109,898 | $458,208,244 | dollars as filed | |
| SQUARESPACE INC | 85225A107 | CLASS A | 10,611,073 | $386,667,500 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC COM | 01625V104 | Stock | 60,993,323 | $302,526,882 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 7,531,252 | $174,047,234 | dollars as filed | |
| EUROPEAN WAX CTR INC | 29882P106 | CLASS A COM | 13,110,492 | $170,174,186 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 5,233,989 | $132,210,562 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 9,681,818 | $109,404,543 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 1,506,684 | $97,934,460 | dollars as filed | |
| HUTCHMED CHINA LTD SPONSORED ADS | 44842L103 | ADR | 4,000,000 | $67,200,000 | dollars as filed | |
| BLEND LABS INC | 09352U108 | CL A | 19,132,440 | $62,180,430 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 1,500,000 | $45,555,000 | dollars as filed | |
| MOBILEYE GLOBAL INC | 60741F104 | COMMON CLASS A | 1,194,839 | $38,414,074 | dollars as filed | |
| RISKIFIED LTD A | M8216R109 | COMMON STOCK | 5,324,998 | $28,808,239 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 2,958,762 | $27,930,713 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 2,889,668 | $19,505,259 | dollars as filed | |
| OPENDOOR TECHNOLOGIES INC | 683712103 | COM | 6,321,519 | $19,154,203 | dollars as filed | |
| CONTEXTLOGIC INC | 21077C305 | COM | 609,616 | $3,468,715 | dollars as filed | |
| GROVE COLLABORATIVE HOLDINGS | 39957D201 | Common Stock | 936,020 | $1,563,153 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 264,000 | $739,200 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950142-24-001354 | this filing | 2024-05-15 | acceptance time not in the bulk data set |